Ai Hua joined Johnson & Johnson more than 25 years ago with a desire to make a difference to the lives of patients. This passion continues today in her role as Company Group Chairman for Janssen Asia Pacific, where she oversees operations that deliver pharmaceutical innovation in Australia, China, Hong Kong, India, Japan, Korea, New Zealand and Taiwan.
Based in her native Singapore, Ai Hua is known for her deep commitment to customers and patients, her strategic insights and global mindset. She is a strong advocate for women in leadership and provides guidance and support through local universities and the Young Women’s Leadership Connection Mentorship Program.
In her previous role as President of One J&J Southeast Asia, Ai Hua was instrumental in the successful implementation of J&J’s first-ever one-company enterprise business model encompassing pharmaceuticals, consumer products and medical devices. She nurtured a business with strong growth and enhanced efficiency across 10 countries in ASEAN.
Ai Hua holds a BSc in Microbiology and Biochemistry and an MBA from the National University of Singapore. She began her healthcare career in 1991 as a product specialist with Johnson & Johnson Medical Singapore. Since then, she has held leadership roles in pharmaceuticals and medical devices working in strategic marketing, sales management, and licensing and acquisition while residing in Singapore, China and the USA.
Ai Hua is a committed volunteer for charitable causes and acts as chair of J&J’s Asia Pacific Contributions Committee. She is also a council member of the Singapore Dover Park Hospice, serves on the Advisory Board of the Singapore Management University Lee Kong Chian School of Business, and was recently appointed to the Board of the DesignSingapore Council.